To overcome the low transduction efficiency of the plasmid expressing GFP-MIP and for inhibiting tumor cell growth, we prepared a synthetic MIP fused to Tat, a cell-permeable peptide (Tat-MIP). This evidence concerns the gene MIP and neoplasm.